Back
Arcus Biosciences, Inc. Vs. Vertex Pharmaceuticals, Inc. Industry Stock Comparison
Sell
26
RCUS
Arcus Biosciences, Inc.
Last Price:
$23.35
Seasonality Move:
-9.85%
Buy
53
VRTX
Vertex Pharmaceuticals, Inc.
Last Price:
$459.71
Seasonality Move:
3%
Sell
26
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. a Buy, Sell or Hold?
-
The current Arcus Biosciences, Inc. [RCUS] share price is $23.09. The Score for RCUS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
RCUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Vertex Pharmaceuticals, Inc. (VRTX)
is a Buy
Is Vertex Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals, Inc. [VRTX] share price is $462.90. The Score for VRTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
VRTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCUS Stock Price Chart
What is Arcus Biosciences, Inc.'s stock price today?
-
The Arcus Biosciences, Inc. share price today is $23.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCUS is experiencing slight buying pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals, Inc.'s stock price today?
-
The Vertex Pharmaceuticals, Inc. share price today is $462.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight buying pressure.
RCUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.24 | Buy |
| Relative Strength Index (14 RSI): | 52.75 | Buy |
| Chaikin Money Flow: | 231619 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 125.54 | Buy |
| Relative Strength Index (14 RSI): | 63.54 | Buy |
| Chaikin Money Flow: | 179442 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (431.97 - 458.77) | Buy |
| Bollinger Bands (100): | (389.73 - 438.33) | Buy |
RCUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.57 | Buy |
| 20-day SMA: | 23.97 | Sell |
| 50-day SMA: | 21.45 | Buy |
| 200-day SMA: | 12.72 | Buy |
| 8-day EMA: | 18.88 | Buy |
| 20-day EMA: | 11.44 | Buy |
| 50-day EMA: | 5.53 | Buy |
| 200-day EMA: | 1.53 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 456.68 | Buy |
| 20-day SMA: | 449.96 | Buy |
| 50-day SMA: | 434.36 | Buy |
| 200-day SMA: | 440.49 | Buy |
| 8-day EMA: | 380.26 | Buy |
| 20-day EMA: | 230.68 | Buy |
| 50-day EMA: | 111.71 | Buy |
| 200-day EMA: | 30.9 | Buy |
Arcus Biosciences, Inc. Earnings Growth & RCUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.37 per share.
Vertex Pharmaceuticals, Inc. Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.96 per share, and an increase next year of $1.79 per share.
Arcus Biosciences, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||